|
|
 |
|
Viewing report
|
|
|
|
The Cancer Market Outlook to 2008
Business Insights, Oct 2003, Pages: 231
The Cancer Market Outlook to 2008, provides a single source of key epidemiological, market and R&D data, together with detailed analysis of current market dynamics and future forecasts to 2008. Despite the fact that many of the gold standard therapies have been available for over a decade, the cancer market is still far from mature. Heavy R&D investment has resulted in over one thousand innovative compounds in clinical development, many of which are now reaching, or are about to reach the market, fuelling further expansion. In the face of this, substantial unmet needs exist in the cancer market and the high incidence of disease is leaving pharmaceutical companies striving to improve the efficacy of treatments to meet this growing demand. Use the latest analysis in this new management report to quantify patient potential in cancer sub-markets, benchmark your strategies against market leaders and identify potential blockbusters of the future.
Customers who bought this item also bought
The Cancer Market Outlook to 2012
Looking at the Cancer Therapy Market
Trends in Cancer Treatment Drugs
Cancer Vaccine Developments to 2013
Cancer Biomarkers: New Tools for Transforming Cancer Management
Worldwide Cancer Market: Trend Analysis
Cancer Vaccine Developments to 2013 + Cancer Vaccine Tracker
Cancer Diagnostic Testing World Markets
Biomarker Technology Platforms for Cancer Diagnoses and Therapies
U.S. Breast Cancer Therapeutics Markets
Cancer Therapies - Global Market Opportunities
Outlook for Cancer Vaccine Development
|
|
|
|
